InvestorsHub Logo
Followers 56
Posts 5540
Boards Moderated 0
Alias Born 11/04/2011

Re: CallMeCrazy post# 96389

Tuesday, 03/31/2015 6:54:06 PM

Tuesday, March 31, 2015 6:54:06 PM

Post# of 403092
This is exactly my thinking as well. The $30M + money left from the previous deal + cash on hand should cover all the trials and operating expenses in one year. Perhaps Nasdaq's request for additional information has something to do with the new Aspire deal?

I smell a PR tomorrow =)

Isn't it also possible Leo is killing "two birds with one stone." The same $30M could be used to meet nasdaq capital listing requirements as well as finance clinical trials. Couldn't it?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News